Zobrazeno 1 - 10
of 41
pro vyhledávání: '"F, Von Koch"'
Autor:
Dieter Grab, C. Anthuber, Marion Kiechle, Sven Mahner, S. Brugger, Jutta Engel, Christian Dannecker, F. von Koch, Miriam Rottmann, Andreas Schnelzer, Martin Pölcher, Christine E Brambs
Publikováno v:
Gynecologic oncology. 154(1)
BACKGROUND According to current treatment guidelines, comprehensive surgical staging procedures in endometrial cancer confined to the uterus depend on uterine risk factors: a systematic lymph node dissection (LND) is recommended in high risk patients
Autor:
Mechthild M. Gross, Cecily Begley, Peter Hillemanns, Mike Clarke, Franz Bahlmann, S Grylka-Baeschlin, M Fleisch, Ralf L. Schild, C von Kaisenberg, F von Koch
Objective: The OptiBIRTH intervention was developed to enhance women-centred care for pregnant women who had had one previous caesarean section. Firstly, systematic reviews and focus group interviews with clinicians and women were carried out. Anothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af254c376dd42d727c5cb365a35bb0c
https://hdl.handle.net/11475/8032
https://hdl.handle.net/11475/8032
Autor:
Valentina Nekljudova, Martina Schmidt, Christian Kurzeder, Gottfried E. Konecny, Miriam Lenhard, Tibor Schuster, Christoph Salat, Elmar Stickeler, Peter A. Fasching, H.-J. Lück, Annette Lebeau, V Müller, Stephan Hasmüller, W Fett, B Liedtke, H. Urbaczyk, S. Loibl, Michael Untch, F. von Koch, Nadia Harbeck, U. Conrad, G. von Minckwitz
Publikováno v:
Annals of Oncology. 22:1988-1998
Background: Preoperative chemotherapy is a recommended treatment of both primary operable and locally advanced breast cancer. Strategies to improve efficacy include the use of anthracyclines, taxanes, and intensified dose with bone marrow support. Pa
Publikováno v:
Annals of Oncology. 16:817-824
Many patients with breast cancer suffer from anaemia, as a consequence of the disease itself or its treatment. Anaemia has a negative impact on treatment outcome and overall survival, and affects the quality of life (QoL) of patients with cancer. Pre
Publikováno v:
Gynäkologisch-geburtshilfliche Rundschau. 44:102-112
Die aus kontrollierten randomisierten Studien gewonnenen Erkenntnisse haben zu einer weiten Verbreitung der adjuvanten endokrinen, zytostatischen oder chemoendokrinen Therapie geführt. Auch für die günstigsten Tumorstadien kann bei positivem Hormo
Autor:
N, Ditsch, A, Vodermaier, A, Hinke, S, Burghardt, M, Lenhard, B, Löhrs, B, Toth, F, Von Koch, S, Kahlert, I, Bauerfeind, G E, Konecny, S, Loibl, G, VON Minckwitz, M, Untch
Publikováno v:
Anticancer research. 32(8)
This post-hoc analysis aimed to compare an intense dose-dense sequential chemotherapy (DD-CT) and a conventionally-dosed chemotherapy (CD-CT) in the neoadjuvant AGO-1 study, focusing on the subgroup with inflammatory breast cancer (IBC).Out of 668 ra
Publikováno v:
Geburtshilfe und Frauenheilkunde. 69
Autor:
Miriam Lenhard, U. Hasbargen, F. von Koch, Klaus Friese, A. Schulze, M. Wichmann, Isabelle Himsl
Publikováno v:
27. Deutscher Krebskongress; 20060322-20060326; Berlin; DOCPE232 /20060320/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77dbcd5b8f997928e3b0a3f565479344
http://www.egms.de/en/meetings/dkk2006/06dkk342.shtml
http://www.egms.de/en/meetings/dkk2006/06dkk342.shtml
Publikováno v:
Gynakologisch-geburtshilfliche Rundschau. 44(2)
The emerging evidence gained from randomized controlled trials accelerated the widespread use of adjuvant endocrine and cytotoxic regimens and their combinations for most breast cancer patients. Even for the earliest cancer stages with low-risk tumou
Publikováno v:
Gynaekologische Geburtshilfliche Rundschau; Apr2004, Vol. 44 Issue 2, p102-112, 11p